Status:
COMPLETED
Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Cancer of the Pancreas
Anorexia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The syndrome of anorexia-cachexie, which accompanies numerous cancers is a major comorbidity which compromises the forecast of these patients. Several cytokines pro-inflammatory as interleukines IL1 ß...
Eligibility Criteria
Inclusion
- Group 1 {cancer of the pancreas WITH syndrome of anorexia-cachexie}
- Patient to hospitalize in the unit of digestive cancer research.
- Patient ≥ 18 years.
- Patient carrier of an adénocarcinome of the pancreas of novo, any stadium confused, diagnosed by imaging and/or histology.
- Existence of at least one of the criteria following to hold(retain) the diagnosis of cachexie cancer patient: not deliberate loss of weight \> in 5 % over the last 6 months OR(WHERE) IMC(CEREBRAL-MOTOR HANDICAPPED) \< 20 kg / m ² with a loss of minimum weight \> 2 % OR(WHERE) scrawny muscular index appendiculaire respectively \< 7,26 kg / m ² at the man and \< 5,45 kg / m ² at the woman with a minimal weight loss \> 2 %.
- Patient having signed the enlightened consent.
Exclusion
- Patient having a tumor other one than the pancreatic adénocarcinome.
- Patient having a second offense of adénocarcinome pancreatic.
- Patient carrier of a pancreatic adénocarcinome in the course of a treatment by chemotherapy.
- Patient having a severe psychiatric comorbidity except TCA who can be responsible for food disorders.
- Patient carrier of an evolutionary inflammatory disease other one than the cancer being able to interfere on the inflammatory status.
- Groupe 2 {cancer du pancréas SANS syndrome d'anorexie-cachexie}
- Inclusion Criteria:
- Patient to hospitalize in the(unit) of digestive cancer research.
- Patient ≥ 18 years.
- Patient carrier of an adénocarcinome of the pancreas of novo, any stadium confused, diagnosed by imaging and/or histology.
- Patient having signed a enlightened consent.
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 24 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02830620
Start Date
August 1 2012
End Date
December 24 2019
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000